Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Anticomplement therapy.
Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
The dual task-cost of standing balance affects quality of life in mildly disabled MS people.
Ischemic Retinal Vasculitis and Its Management.
B cell-directed therapies in multiple sclerosis.
[Blood and cerebrospinal fluid test in multiple sclerosis].
Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
Scale Adjustments to Facilitate Two-Dimensional Measurements in OCT Images.
Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?
Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders.
Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
Emerging roles of microRNAs in chronic pain.
LINGO-1 regulates oligodendrocyte differentiation by inhibiting ErbB2 translocation and activation in lipid rafts.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Recurrent Optic Neuritis in Children.
Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series.
Should Plasma Exchange Be Offered to Patients With Multiple Sclerosis-Associated Optic Neuritis?
Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Immune-mediated processes in neurodegeneration: where do we stand?

Pages